Farallon Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Farallon Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-90,000	Closed	-$2.17M	–	199
2023 Q1	$2.17M	Buy	+90,000	New	+$1.13M	0.01%	136

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Farallon Capital Management's PRVB Position: Q2 2023 in Review

Farallon Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 90,000 shares — an estimated $2.17M sold.

Farallon Capital Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $2.17M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Farallon Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Farallon Capital Management sold 90,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.17M.
Farallon Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Farallon Capital Management's Provention Bio, Inc. Common Stock position peaked at $2.17M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.